CASE STUDY: Januvia's Hasty Arrival
Merck plays 'to win' in one of its first launches since implementing a new cost-cutting model.
Returning the Favor
Multi-company campaign hopes to cast clinical trial participants as 'heroes.'
Lost in the Sauce
Government report paints picture of ineffectual FDA buried by avalanche of ads.
